ServiziMenu principaleHome


4th ESO-ESMO Breast Cancer in Young Women International Conference

6-8 October 2018, Lugano, Switzerland

Chair: O. Pagani, CH 
Scientific Committee: F. Cardoso, PT - N. Harbeck, DE - S. Paluch-Shimon, IL - A.H. Partridge, US - F.A. Peccatori, IT - E. Senkus, PL - Y. Wengström, SE

For more information, click HERE

The flyer of the event is available HERE

Breast cancer in young women is a complex disease, occurring when these women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women. Many aspects of breast cancer in young women are therefore poorly understood (e.g. etiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the longterm effects of treatment or the consequences of recurrent disease. This third conference is a new opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations. It will cover epidemiology, molecular biology, genetics, pathology, surgery, radiotherapy, systemic therapy, survivorship issues (e.g.fertility preservation, psychosocial needs) in young women with breast cancer.

It will also include a Consensus Session that will form the basis for a Consensus Guidelines manuscript to be published after the Conference. We hope that you will join us and contribute to further develop the understanding and treatment of this disease.

• In depth learning and update of the scientific and clinical aspects of breast cancer in young women
• Highlight the importance of multi-disciplinary management and discuss difficult clinical cases
• Focus on clinical research priorities and future perspectives, involving patients’ advocates in setting the agenda
• Participate in the discussion of consensus guidelines

• Epidemiology of early and advanced disease
• Biology
• Hereditary breast cancer
• Diagnostic tools and challenges
• Loco-regional therapy
• Systemic therapy
• Psychosocial aspects and survivorship

• Medical oncologists
• Surgeons
• Gynecologists
• Radiation oncologists
• Breast radiologists
• Onco-geneticists
• Pathologists
• Nurses
• Patient advocates
• Phycho-oncologists


  Early rate
(by 17 June 2018)
Late rate
(by 23 September 2018)
(from 24 September 2018)
Registration fee EUR 380 EUR 480 EUR 580
BCN discount EUR 300    


Travel grants: 6 May 2018
Abstracts: 6 May 2018
Early registration: by 17 June 2018
Late registration: by 23 September 2018
On-site registration: from 24 September 2018